Tenderwize
Wróć do wyszukiwania

Open House Discount Contracts for Amifampridin (ATC N07XX05)

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Amifampridin, ATC N07XX05

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Amifampridin (ATC N07XX05) to be supplied to the AOK Rheinland-Pfalz/Saarland.
  • Standardized contract terms; no negotiations.
Pokaż pełne podsumowanie

This is a non-exclusive open-house procedure for pharmaceutical discount contracts for the active ingredient Amifampridin (ATC N07XX05), organized by AOK Rheinland-Pfalz/Saarland. The procedure allows any interested pharmaceutical company to enter into standardized discount agreements without competitive selection. Contracts run up to 24 months from the earliest start date (01.05.2025) and can be terminated automatically if the buyer awards exclusive contracts. The notice is published voluntarily for transparency and is not subject to EU procurement law despite using the standard form.

Ryzyka

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Pharmaceutical companies must be authorized to market Amifampridin in Germany.
  • Drugs must be approved and marketable in Germany, proven by Lauer-Taxe listing or AMIce database extracts.

Administrative

  • Physical submission of signed contract documents; electronic submission not allowed.

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Contracts for Amifampridin (ATC N07XX05)

Non-exclusive discount contracts for Amifampridin with standardized terms. No negotiations, no exclusivity. Contracts end at the latest 24 months after the first contract start (01.05.2025), regardless of individual start dates. The buyer may replace these contracts with exclusive contracts at any time, causing automatic termination.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

Apr 2025 - Apr 2027

Kategoria

Pharmaceutical products

Termin

Deadline Feb 28, 2027

Szczegóły zamówienia

Data publikacji
12 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
164018-2025

Dokumenty (1)

Podobne przetargi